154 related articles for article (PubMed ID: 20209442)
1. Estrogenic in vitro assay on mouse embryonic Leydig cells.
La Sala G; Farini D; De Felici M
Int J Dev Biol; 2010; 54(4):717-22. PubMed ID: 20209442
[TBL] [Abstract][Full Text] [Related]
2. Determining the transrepression activity of xenoestrogen on nuclear factor-kappa B in Cos-1 cells by estrogen receptor-alpha.
Ansari RA; Gandy J
Int J Toxicol; 2007; 26(5):441-9. PubMed ID: 17963131
[TBL] [Abstract][Full Text] [Related]
3. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of estrogenic/antiestrogenic activity of Onobrychis ebenoides extract - interaction with estrogen receptor subtypes ERalpha and ERbeta.
Papoutsi Z; Kassi E; Halabalaki M; Mitakou S; Moutsatsou P
Toxicol In Vitro; 2007 Apr; 21(3):364-70. PubMed ID: 17092687
[TBL] [Abstract][Full Text] [Related]
6. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
7. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-like activities of saikosaponin-d in vitro: a pilot study.
Wang P; Ren J; Tang J; Zhang D; Li B; Li Y
Eur J Pharmacol; 2010 Jan; 626(2-3):159-65. PubMed ID: 19819234
[TBL] [Abstract][Full Text] [Related]
9. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay.
Freyberger A; Schmuck G
Toxicol Lett; 2005 Jan; 155(1):1-13. PubMed ID: 15585354
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
[TBL] [Abstract][Full Text] [Related]
11. ERα/E2 signaling suppresses the expression of steroidogenic enzyme genes via cross-talk with orphan nuclear receptor Nur77 in the testes.
Lee SY; Park E; Kim SC; Ahn RS; Ko C; Lee K
Mol Cell Endocrinol; 2012 Oct; 362(1-2):91-103. PubMed ID: 22683664
[TBL] [Abstract][Full Text] [Related]
12. Does 4-tert-octylphenol affect estrogen signaling pathways in bank vole Leydig cells and tumor mouse Leydig cells in vitro?
Kotula-Balak M; Chojnacka K; Hejmej A; Galas J; Satola M; Bilinska B
Reprod Toxicol; 2013 Aug; 39():6-16. PubMed ID: 23557686
[TBL] [Abstract][Full Text] [Related]
13. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic activity in white and red wine extracts.
Klinge CM; Risinger KE; Watts MB; Beck V; Eder R; Jungbauer A
J Agric Food Chem; 2003 Mar; 51(7):1850-7. PubMed ID: 12643641
[TBL] [Abstract][Full Text] [Related]
15. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of wild-type estrogen receptor alpha and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells.
Wu F; Safe S
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):1-9. PubMed ID: 17141713
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
18. In vitro estrogenic activity of formononetin by two bioassay systems.
Ji ZN; Zhao WY; Liao GR; Choi RC; Lo CK; Dong TT; Tsim KW
Gynecol Endocrinol; 2006 Oct; 22(10):578-84. PubMed ID: 17135037
[TBL] [Abstract][Full Text] [Related]
19. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.
Legler J; van den Brink CE; Brouwer A; Murk AJ; van der Saag PT; Vethaak AD; van der Burg B
Toxicol Sci; 1999 Mar; 48(1):55-66. PubMed ID: 10330684
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of estrogenic/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta.
Papoutsi Z; Kassi E; Tsiapara A; Fokialakis N; Chrousos GP; Moutsatsou P
J Agric Food Chem; 2005 Oct; 53(20):7715-20. PubMed ID: 16190622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
